Product NDC: | 64253-202 |
Proprietary Name: | sodium chloride |
Non Proprietary Name: | sodium chloride |
Active Ingredient(s): | 9 mg/mL & nbsp; sodium chloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64253-202 |
Labeler Name: | Medefil, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202832 |
Marketing Category: | NDA |
Start Marketing Date: | 20120113 |
Package NDC: | 64253-202-33 |
Package Description: | 60 SYRINGE, PLASTIC in 1 BOX (64253-202-33) > 3 mL in 1 SYRINGE, PLASTIC |
NDC Code | 64253-202-33 |
Proprietary Name | sodium chloride |
Package Description | 60 SYRINGE, PLASTIC in 1 BOX (64253-202-33) > 3 mL in 1 SYRINGE, PLASTIC |
Product NDC | 64253-202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sodium chloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20120113 |
Marketing Category Name | NDA |
Labeler Name | Medefil, Inc. |
Substance Name | SODIUM CHLORIDE |
Strength Number | 9 |
Strength Unit | mg/mL |
Pharmaceutical Classes |